title: Nevirapine-associated rash in a Jamaican child with HIV/AIDS.
abstract: Nevirapine is one of the first line antiretroviral agents used in the treatment of HIV/AIDS as well as for prophylaxis against mother-to-child transmission of HIV As antiretroviral medication becomes more available it is important for physicians to recognize the major clinical toxicities of these medications. We report a HIV-infected infant who developed a rash with systemic symptoms in association with nevirapine administration.
authors.affiliation: The University of the West Indies, Kingston, Jamaica.
authors.forename: J C
authors.initials: JC
authors.lastname: Steel-Duncan
authors.forename: R
authors.initials: R
authors.lastname: Pierre
authors.forename: L
authors.initials: L
authors.lastname: Gabay
authors.forename: C D C
authors.initials: CD
authors.lastname: Christie
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D019380:Anti-HIV Agents / Q000009:adverse effects*; D005076:Exanthema / Q000139:chemically induced* / Q000503:physiopathology; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007563:Jamaica; D008297:Male; D019829:Nevirapine / Q000009:adverse effects*
chemical_list: D019380:Anti-HIV Agents; D019829:Nevirapine